How do you treat patients with hyperkalemia?

STEVEN

63 years old

CKD Stage 4, hypertension, type 2 diabetes with recurrent hyperkalemia

“I’m worried about whether my current treatment plan will keep my potassium levels under control. I also struggle with maintaining a diet for my conditions.”

Patient previously treated episodically
Patient previously treated episodically

See Steven’s treatment journey

  • Previously prescribed SPS episodically to address recurrent hyperkalemic events, and recommended to dietitian for low-K+ diet
  • Experienced GI side effects from SPS
  • Recent lab results show another hyperkalemia occurrence within 3 months, with a serum K+ level of 5.7 mEq/L

PRESCRIBED LOKELMA:

Achieved and maintained normokalemia for 1 year with continued treatment and without the requirement of low-K+ diet modification

Appreciated that LOKELMA is tasteless and odorless

Individual is a hypothetical patient, not an actual patient.

CKD=chronic kidney disease; GI=gastrointestinal; SPS=sodium polystyrene sulfonate.

SOFIA

58 years old

CKD Stage 3b, type 2 diabetes, hypertension with recurrent hyperkalemia

“It’s difficult for me to manage all my conditions and dietary restrictions. I fear what might come next.”

Patient currently on RAAS inhibitors
Patient currently on RAAS inhibitors

See Sofia’s treatment journey

  • Patient has difficulty adhering to low-K+ diet in addition to diabetes diet
  • Physician previously reduced her RAAS inhibitor dose to further manage her hyperkalemia
  • Recent lab results show that the patient is still hyperkalemic, with serum K+ levels of 5.5 mEq/L

PRESCRIBED LOKELMA:

Achieved and maintained normokalemia for 1 year with continued use and without the requirement of low-K+ diet modification

Guideline-recommended RAAS inhibitor use was reinitiated

Individual is a hypothetical patient, not an actual patient.

CKD=chronic kidney disease; RAAS=renin-angiotensin-aldosterone system.

Learn more about how LOKELMA can help patients across all settings